Revvity Inc (RVTY) reports robust Q4 results with 6% organic growth and a 30.3% adjusted operating margin, while navigating challenges in life science instrumentation. Life sciences company ...

State of Alaska Department of Revenue lessened its stake in shares of Revvity, Inc. (NYSE:RVTY – Free Report) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 13,877 shares ...

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents ...

In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...

The life sciences industry is experiencing an identity crisis. The life sciences industry has a unique social contract with the public, given its role in developing and commercializing therapies ...

A recent study presents a new way to understand life by describing it as a cascade of machines producing machines, spanning ...

Shares of Revvity Inc. RVTY shed 3.38% to $114.84 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to 6,066.44 and ...

Researchers have used artificial intelligence (AI) to design brand-new enzymes that can go through multi-step reactions, a ...

Synthetic cells that look just like natural cells but are chemically reversed could outcompete other living organisms − with ...